United States Biotechnology & Medical Research

Aura Biosciences Inc (AURA)

Track

Track

Aura Biosciences Inc. experienced multiple insider trading transactions throughout early 2026. The most recent activity occurred on June 16, 2026, involving officer sales. Previous months also saw significant divestments by various executives and institutional holders. These patterns reflect consistent selling behavior among leadership, with no reported acquisitions during this observed timeframe.
Ticker: AURA Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Aura Biosciences Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.8
Gibney Anthony Officer Officer
Transaction date
Proposed sale
Price
400.45
Quantity 63,202
Value US$4,721,921
2.8
Gibney Anthony S See Remarks Officer
Transaction date
Sale
Price
149.93
Quantity 54,013 +48.2%
Value US$2,927,701
1.5
Kilroy Conor Officer Officer
Transaction date
Proposed sale
Price
7.02
Quantity 11,738
Value US$82,402
1.5
Kilroy Conor See Remarks Officer
Transaction date
Sale
Price
7.02
Quantity 11,738 -5.1%
Value US$82,401
1.5
Kilroy Conor Officer Officer
Transaction date
Proposed sale
Price
5.05
Quantity 12,079
Value US$61,037
2.8
Elazzouzi Amy Officer Officer
Transaction date
Proposed sale
Price
5.06
Quantity 8,549
Value US$43,261
2.4
Hopkins Janet Jill Officer Officer
Transaction date
Proposed sale
Price
5.06
Quantity 20,401
Value US$103,231
2.8
de los Pinos Elisabet Officer; Director Executive Director
Transaction date
Proposed sale
Price
5.06
Quantity 47,648
Value US$241,063
3.0
Plavsic Mark Officer Officer
Transaction date
Proposed sale
Price
5.05
Quantity 15,890
Value US$80,271
2.4
Hopkins Janet Jill Chief Medical Officer Officer
Transaction date
Sale
Price
5.06
Quantity 20,401 -8.1%
Value US$103,229
1.5
Kilroy Conor See Remarks Officer
Transaction date
Sale
Price
5.05
Quantity 12,079 -6.7%
Value US$60,999
3.0
Plavsic Mark Chief Technology Officer Officer
Transaction date
Sale
Price
5.05
Quantity 15,890 -8.1%
Value US$80,244
2.8
de los Pinos Elisabet See Remarks Executive Director
Transaction date
Sale
Price
5.06
Quantity 47,648 -10.4%
Value US$241,099
2.8
Elazzouzi Amy Senior Vice President, Finance Officer
Transaction date
Sale
Price
5.06
Quantity 8,549 -10.2%
Value US$43,258
2.8
Elazzouzi Amy Officer Officer
Transaction date
Proposed sale
Price
4.86
Quantity 1,581
Value US$7,684
2.8
de los Pinos Elisabet Officer; Director Executive Director
Transaction date
Proposed sale
Price
4.86
Quantity 16,928
Value US$82,234
2.8
Elazzouzi Amy Senior Vice President, Finance Officer
Transaction date
Sale
Price
4.86
Quantity 1,581 -1.8%
Value US$7,684
2.8
de los Pinos Elisabet See Remarks Executive Director
Transaction date
Sale
Price
4.86
Quantity 16,928 -3.6%
Value US$82,270
2.4
Hopkins Janet Jill Officer Officer
Transaction date
Proposed sale
Price
5.42
Quantity 17,109
Value US$92,735
2.4
Hopkins Janet Jill Chief Medical Officer Officer
Transaction date
Sale
Price
5.42
Quantity 17,109 -6.3%
Value US$92,731
2.8
Elazzouzi Amy Officer Officer
Transaction date
Proposed sale
Price
6.35
Quantity 896
Value US$5,690
2.8
de los Pinos Elisabet Officer; Director Executive Director
Transaction date
Proposed sale
Price
6.35
Quantity 9,049
Value US$57,461
2.8
Elazzouzi Amy Senior Vice President, Finance Officer
Transaction date
Sale
Price
6.35
Quantity 896 -1.0%
Value US$5,690
2.8
de los Pinos Elisabet See Remarks Executive Director
Transaction date
Sale
Price
6.35
Quantity 9,049 -1.9%
Value US$57,461
3.0
Plavsic Mark Officer Officer
Transaction date
Proposed sale
Price
6.35
Quantity 12,169
Value US$77,273
3.0
Plavsic Mark Chief Technology Officer Officer
Transaction date
Sale
Price
6.35
Quantity 12,169 -5.8%
Value US$77,273
2.8
AMY F ELAZZOUZI Officer Officer
Transaction date
Proposed sale
Price
6.70
Quantity 7,722
Value US$51,751
2.8
Elazzouzi Amy Senior Vice President, Finance Officer
Transaction date
Sale
Price
6.70
Quantity 7,722 -8.2%
Value US$51,737
3.8
Johnson David Michael Non-Executive Director
Transaction date
Purchase
Price
4.90
Quantity 20,000 +13.7%
Value US$98,000
2.8
Gibney Anthony S See Remarks Officer
Transaction date
Sale
Price
5.15
Quantity 1,519 -2.6%
Value US$7,823
2.8
Gibney Anthony S See Remarks Officer
Transaction date
Purchase
Price
4.90
Quantity 50,000 +591.6%
Value US$245,000
2.8
Gibney Anthony Officer Officer
Transaction date
Proposed sale
Price
5.15
Quantity 1,519
Value US$7,823
2.8
Elazzouzi Amy Officer Officer
Transaction date
Proposed sale
Price
5.49
Quantity 897
Value US$4,925
1.5
Kilroy Conor Officer Officer
Transaction date
Proposed sale
Price
5.49
Quantity 7,162
Value US$39,319
2.8
Elazzouzi Amy Senior Vice President, Finance Officer
Transaction date
Sale
Price
5.49
Quantity 897 -1.1%
Value US$4,925
1.5
Kilroy Conor See Remarks Officer
Transaction date
Sale
Price
5.49
Quantity 7,162 -3.8%
Value US$39,319
3.0
Plavsic Mark Officer Officer
Transaction date
Proposed sale
Price
7.75
Quantity 2,151
Value US$16,670
2.4
Hopkins Janet Jill Officer Officer
Transaction date
Proposed sale
Price
7.75
Quantity 2,534
Value US$19,639
2.8
Elazzouzi Amy Officer Officer
Transaction date
Proposed sale
Price
7.75
Quantity 1,404
Value US$10,881
2.8
de los Pinos Elisabet Officer; Director Executive Director
Transaction date
Proposed sale
Price
7.75
Quantity 20,221
Value US$156,796
3.0
Plavsic Mark Chief Technology Officer Officer
Transaction date
Sale
Price
7.75
Quantity 2,151 -1.0%
Value US$16,670
2.4
Hopkins Janet Jill Chief Medical Officer Officer
Transaction date
Sale
Price
7.75
Quantity 2,534 -0.9%
Value US$19,638
2.8
de los Pinos Elisabet See Remarks Executive Director
Transaction date
Sale
Price
7.75
Quantity 20,221 -4.0%
Value US$156,796
2.8
Elazzouzi Amy Senior Vice President, Finance Officer
Transaction date
Sale
Price
7.75
Quantity 1,404 -1.7%
Value US$10,881
2.8
de los Pinos Elisabet Officer; Director Executive Director
Transaction date
Proposed sale
Price
7.67
Quantity 15,955
Value US$122,381
2.8
Elazzouzi Amy Officer Officer
Transaction date
Proposed sale
Price
7.67
Quantity 1,001
Value US$7,679
2.8
de los Pinos Elisabet See Remarks Executive Director
Transaction date
Sale
Price
7.67
Quantity 15,955 -5.0%
Value US$122,381
2.8
Elazzouzi Amy Vice President, Finance Officer
Transaction date
Sale
Price
7.67
Quantity 1,001 -2.5%
Value US$7,679
2.4
Janet Jill Hopkins Officer Officer
Transaction date
Proposed sale
Price
9.36
Quantity 11,822
Value US$110,663
2.4
Hopkins Janet Jill Chief Medical Officer Officer
Transaction date
Sale
Price
9.36
Quantity 11,822 -7.2%
Value US$110,663
2.8
Amy Elazzouzi Officer Officer
Transaction date
Proposed sale
Price
10.74
Quantity 553
Value US$5,938
2.8
Elisabet de los Pinos Officer; Director Executive Director
Transaction date
Proposed sale
Price
10.74
Quantity 9,200
Value US$98,788
1.9
Julie B. Feder Former Officer Officer
Transaction date
Proposed sale
Price
10.74
Quantity 3,249
Value US$34,889
2.8
de los Pinos Elisabet See Remarks Executive Director
Transaction date
Sale
Price
10.74
Quantity 9,200 -2.8%
Value US$98,788
2.8
Elazzouzi Amy Vice President, Finance Officer
Transaction date
Sale
Price
10.74
Quantity 553 -1.4%
Value US$5,938
1.9
Feder Julie B Chief Financial Officer Officer
Transaction date
Planned sale
Price
12.03
Quantity 25,131 -15.8%
Value US$302,361
1.9
JULIE FEDER Officer Officer
Transaction date
Proposed sale
Price
10.29
Quantity 25,131
Value US$258,598
2.8
ELISABET DE LOS PINOS Director; Officer Executive Director
Transaction date
Proposed sale
Price
10.29
Quantity 24,992
Value US$257,168
2.8
de los Pinos Elisabet See Remarks Executive Director
Transaction date
Planned sale
Price
12.04
Quantity 24,992 -7.0%
Value US$300,839
3.0
Plavsic Mark Officer Officer
Transaction date
Proposed sale
Price
9.85
Quantity 7,383
Value US$72,723
3.0
Plavsic Mark Chief Technology Officer Officer
Transaction date
Sale
Price
9.85
Quantity 7,383 -5.7%
Value US$72,723
CADMUS C RICH & SHANTEL C RICH Officer Officer
Transaction date
Proposed sale
Price
8.73
Quantity 15,974
Value US$139,453
1.9
Julie B. Feder Officer Officer
Transaction date
Proposed sale
Price
7.64
Quantity 6,609
Value US$50,521
2.8
Elisabet de los Pinos Officer; Director Executive Director
Transaction date
Proposed sale
Price
7.64
Quantity 15,853
Value US$121,141
1.9
Feder Julie B Chief Financial Officer Officer
Transaction date
Sale
Price
7.64
Quantity 6,609 -9.5%
Value US$50,521
2.8
de los Pinos Elisabet See Remarks Executive Director
Transaction date
Sale
Price
7.64
Quantity 15,853 -8.9%
Value US$121,141
3.8
Johnson David Michael Non-Executive Director
Transaction date
Purchase
Price
7.30
Quantity 10,000 +15.4%
Value US$73,000
3.8
Johnson David Michael Non-Executive Director
Transaction date
Purchase
Price
7.30
Quantity 10,000 +15.4%
Value US$73,000
3.8
Johnson David Michael Non-Executive Director
Transaction date
Purchase
Price
7.30
Quantity 9,601 +7.6%
Value US$70,087
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-16 2026-06-16 PrS Proposed sale
2.8
Gibney Anthony

Officer

Officer
63,202
400.45
US$4,721,921 		63,202 400.45 US$4,721,921
2026-06-16 2026-06-16 S Sale
2.8
Gibney Anthony S

See Remarks

Officer
54,013 +48.2%
149.93
US$2,927,701 		54,013 +48.2% 149.93 US$2,927,701
2026-05-11 2026-05-07 S Sale
1.1
Matrix Capital Management Company, LP
Large shareholder
73,353 +33.7%
262.69
US$4,767,711 		73,353 +33.7% 262.69 US$4,767,711
2026-04-16 2026-04-16 PrS Proposed sale
1.5
Kilroy Conor

Officer

Officer
11,738
7.02
US$82,402 		11,738 7.02 US$82,402
2026-04-16 2026-04-16 S Sale
1.5
Kilroy Conor

See Remarks

Officer
11,738 -5.1%
7.02
US$82,401 		11,738 -5.1% 7.02 US$82,401
2026-02-17 2026-02-17 PrS Proposed sale
1.5
Kilroy Conor

Officer

Officer
12,079
5.05
US$61,037 		12,079 5.05 US$61,037
2026-02-17 2026-02-17 PrS Proposed sale
2.8
Elazzouzi Amy

Officer

Officer
8,549
5.06
US$43,261 		8,549 5.06 US$43,261
2026-02-17 2026-02-17 PrS Proposed sale
2.4
Hopkins Janet Jill

Officer

Officer
20,401
5.06
US$103,231 		20,401 5.06 US$103,231
2026-02-17 2026-02-17 PrS Proposed sale
2.8
de los Pinos Elisabet

Officer; Director

Executive Director
47,648
5.06
US$241,063 		47,648 5.06 US$241,063
2026-02-17 2026-02-17 PrS Proposed sale
3.0
Plavsic Mark

Officer

Officer
15,890
5.05
US$80,271 		15,890 5.05 US$80,271
2026-02-17 2026-02-17 S Sale
2.4
Hopkins Janet Jill

Chief Medical Officer

Officer
20,401 -8.1%
5.06
US$103,229 		20,401 -8.1% 5.06 US$103,229
2026-02-17 2026-02-17 S Sale
1.5
Kilroy Conor

See Remarks

Officer
12,079 -6.7%
5.05
US$60,999 		12,079 -6.7% 5.05 US$60,999
2026-02-17 2026-02-17 S Sale
3.0
Plavsic Mark

Chief Technology Officer

Officer
15,890 -8.1%
5.05
US$80,244 		15,890 -8.1% 5.05 US$80,244
2026-02-17 2026-02-17 S Sale
2.8
de los Pinos Elisabet

See Remarks

Executive Director
47,648 -10.4%
5.06
US$241,099 		47,648 -10.4% 5.06 US$241,099
2026-02-17 2026-02-17 S Sale
2.8
Elazzouzi Amy

Senior Vice President, Finance

Officer
8,549 -10.2%
5.06
US$43,258 		8,549 -10.2% 5.06 US$43,258
2026-01-20 2026-01-20 PrS Proposed sale
2.8
Elazzouzi Amy

Officer

Officer
1,581
4.86
US$7,684 		1,581 4.86 US$7,684
2026-01-20 2026-01-20 PrS Proposed sale
2.8
de los Pinos Elisabet

Officer; Director

Executive Director
16,928
4.86
US$82,234 		16,928 4.86 US$82,234
2026-01-20 2026-01-20 S Sale
2.8
Elazzouzi Amy

Senior Vice President, Finance

Officer
1,581 -1.8%
4.86
US$7,684 		1,581 -1.8% 4.86 US$7,684
2026-01-20 2026-01-20 S Sale
2.8
de los Pinos Elisabet

See Remarks

Executive Director
16,928 -3.6%
4.86
US$82,270 		16,928 -3.6% 4.86 US$82,270
2025-11-17 2025-11-17 PrS Proposed sale
2.4
Hopkins Janet Jill

Officer

Officer
17,109
5.42
US$92,735 		17,109 5.42 US$92,735
2025-11-17 2025-11-17 S Sale
2.4
Hopkins Janet Jill

Chief Medical Officer

Officer
17,109 -6.3%
5.42
US$92,731 		17,109 -6.3% 5.42 US$92,731
2025-10-29 2025-10-29 PrS Proposed sale
2.8
Elazzouzi Amy

Officer

Officer
896
6.35
US$5,690 		896 6.35 US$5,690
2025-10-29 2025-10-29 PrS Proposed sale
2.8
de los Pinos Elisabet

Officer; Director

Executive Director
9,049
6.35
US$57,461 		9,049 6.35 US$57,461
2025-10-29 2025-10-29 S Sale
2.8
Elazzouzi Amy

Senior Vice President, Finance

Officer
896 -1.0%
6.35
US$5,690 		896 -1.0% 6.35 US$5,690
2025-10-29 2025-10-29 S Sale
2.8
de los Pinos Elisabet

See Remarks

Executive Director
9,049 -1.9%
6.35
US$57,461 		9,049 -1.9% 6.35 US$57,461
2025-10-16 2025-10-16 PrS Proposed sale
3.0
Plavsic Mark

Officer

Officer
12,169
6.35
US$77,273 		12,169 6.35 US$77,273
2025-10-16 2025-10-16 S Sale
3.0
Plavsic Mark

Chief Technology Officer

Officer
12,169 -5.8%
6.35
US$77,273 		12,169 -5.8% 6.35 US$77,273
2025-08-18 2025-08-18 PrS Proposed sale
2.8
AMY F ELAZZOUZI

Officer

Officer
7,722
6.70
US$51,751 		7,722 6.70 US$51,751
2025-08-18 2025-08-18 S Sale
2.8
Elazzouzi Amy

Senior Vice President, Finance

Officer
7,722 -8.2%
6.70
US$51,737 		7,722 -8.2% 6.70 US$51,737
2025-05-20 2025-05-16 B Purchase
3.8
Johnson David Michael
Non-Executive Director
20,000 +13.7%
4.90
US$98,000 		20,000 +13.7% 4.90 US$98,000
2025-05-20 2025-05-16 S Sale
2.8
Gibney Anthony S

See Remarks

Officer
1,519 -2.6%
5.15
US$7,823 		1,519 -2.6% 5.15 US$7,823
2025-05-20 2025-05-16 B Purchase
2.8
Gibney Anthony S

See Remarks

Officer
50,000 +591.6%
4.90
US$245,000 		50,000 +591.6% 4.90 US$245,000
2025-05-16 2025-05-16 PrS Proposed sale
2.8
Gibney Anthony

Officer

Officer
1,519
5.15
US$7,823 		1,519 5.15 US$7,823
2025-04-16 2025-04-16 PrS Proposed sale
2.8
Elazzouzi Amy

Officer

Officer
897
5.49
US$4,925 		897 5.49 US$4,925
2025-04-16 2025-04-16 PrS Proposed sale
1.5
Kilroy Conor

Officer

Officer
7,162
5.49
US$39,319 		7,162 5.49 US$39,319
2025-04-16 2025-04-16 S Sale
2.8
Elazzouzi Amy

Senior Vice President, Finance

Officer
897 -1.1%
5.49
US$4,925 		897 -1.1% 5.49 US$4,925
2025-04-16 2025-04-16 S Sale
1.5
Kilroy Conor

See Remarks

Officer
7,162 -3.8%
5.49
US$39,319 		7,162 -3.8% 5.49 US$39,319
2025-02-18 2025-02-18 PrS Proposed sale
3.0
Plavsic Mark

Officer

Officer
2,151
7.75
US$16,670 		2,151 7.75 US$16,670
2025-02-18 2025-02-18 PrS Proposed sale
2.4
Hopkins Janet Jill

Officer

Officer
2,534
7.75
US$19,639 		2,534 7.75 US$19,639
2025-02-18 2025-02-18 PrS Proposed sale
2.8
Elazzouzi Amy

Officer

Officer
1,404
7.75
US$10,881 		1,404 7.75 US$10,881
2025-02-18 2025-02-18 PrS Proposed sale
2.8
de los Pinos Elisabet

Officer; Director

Executive Director
20,221
7.75
US$156,796 		20,221 7.75 US$156,796
2025-02-18 2025-02-18 S Sale
3.0
Plavsic Mark

Chief Technology Officer

Officer
2,151 -1.0%
7.75
US$16,670 		2,151 -1.0% 7.75 US$16,670
2025-02-18 2025-02-18 S Sale
2.4
Hopkins Janet Jill

Chief Medical Officer

Officer
2,534 -0.9%
7.75
US$19,638 		2,534 -0.9% 7.75 US$19,638
2025-02-18 2025-02-18 S Sale
2.8
de los Pinos Elisabet

See Remarks

Executive Director
20,221 -4.0%
7.75
US$156,796 		20,221 -4.0% 7.75 US$156,796
2025-02-18 2025-02-18 S Sale
2.8
Elazzouzi Amy

Senior Vice President, Finance

Officer
1,404 -1.7%
7.75
US$10,881 		1,404 -1.7% 7.75 US$10,881
2025-01-21 2025-01-21 PrS Proposed sale
2.8
de los Pinos Elisabet

Officer; Director

Executive Director
15,955
7.67
US$122,381 		15,955 7.67 US$122,381
2025-01-21 2025-01-21 PrS Proposed sale
2.8
Elazzouzi Amy

Officer

Officer
1,001
7.67
US$7,679 		1,001 7.67 US$7,679
2025-01-21 2025-01-21 S Sale
2.8
de los Pinos Elisabet

See Remarks

Executive Director
15,955 -5.0%
7.67
US$122,381 		15,955 -5.0% 7.67 US$122,381
2025-01-21 2025-01-21 S Sale
2.8
Elazzouzi Amy

Vice President, Finance

Officer
1,001 -2.5%
7.67
US$7,679 		1,001 -2.5% 7.67 US$7,679
2024-11-18 2024-11-18 PrS Proposed sale
2.4
Janet Jill Hopkins

Officer

Officer
11,822
9.36
US$110,663 		11,822 9.36 US$110,663
2024-11-18 2024-11-18 S Sale
2.4
Hopkins Janet Jill

Chief Medical Officer

Officer
11,822 -7.2%
9.36
US$110,663 		11,822 -7.2% 9.36 US$110,663
2024-10-29 2024-10-29 PrS Proposed sale
2.8
Amy Elazzouzi

Officer

Officer
553
10.74
US$5,938 		553 10.74 US$5,938
2024-10-29 2024-10-29 PrS Proposed sale
2.8
Elisabet de los Pinos

Officer; Director

Executive Director
9,200
10.74
US$98,788 		9,200 10.74 US$98,788
2024-10-29 2024-10-29 PrS Proposed sale
1.9
Julie B. Feder

Former Officer

Officer
3,249
10.74
US$34,889 		3,249 10.74 US$34,889
2024-10-29 2024-10-29 S Sale
2.8
de los Pinos Elisabet

See Remarks

Executive Director
9,200 -2.8%
10.74
US$98,788 		9,200 -2.8% 10.74 US$98,788
2024-10-29 2024-10-29 S Sale
2.8
Elazzouzi Amy

Vice President, Finance

Officer
553 -1.4%
10.74
US$5,938 		553 -1.4% 10.74 US$5,938
2024-10-21 2024-10-18 PlS Planned sale
1.9
Feder Julie B

Chief Financial Officer

Officer
25,131 -15.8%
12.03
US$302,361 		25,131 -15.8% 12.03 US$302,361
2024-10-18 2024-10-18 PrS Proposed sale
1.9
JULIE FEDER

Officer

Officer
25,131
10.29
US$258,598 		25,131 10.29 US$258,598
2024-10-18 2024-10-18 PrS Proposed sale
2.8
ELISABET DE LOS PINOS

Director; Officer

Executive Director
24,992
10.29
US$257,168 		24,992 10.29 US$257,168
2024-10-18 2024-10-18 PlS Planned sale
2.8
de los Pinos Elisabet

See Remarks

Executive Director
24,992 -7.0%
12.04
US$300,839 		24,992 -7.0% 12.04 US$300,839
2024-10-16 2024-10-16 PrS Proposed sale
3.0
Plavsic Mark

Officer

Officer
7,383
9.85
US$72,723 		7,383 9.85 US$72,723
2024-10-16 2024-10-16 S Sale
3.0
Plavsic Mark

Chief Technology Officer

Officer
7,383 -5.7%
9.85
US$72,723 		7,383 -5.7% 9.85 US$72,723
2024-03-04 2024-03-04 PrS Proposed sale
CADMUS C RICH & SHANTEL C RICH

Officer

Officer
20,000
9.24
US$184,800 		20,000 9.24 US$184,800
2024-02-23 2024-02-23 PrS Proposed sale
CADMUS C RICH & SHANTEL C RICH

Officer

Officer
15,974
8.73
US$139,453 		15,974 8.73 US$139,453
2024-01-24 2024-01-23 PrS Proposed sale
1.9
Julie B. Feder

Officer

Officer
6,609
7.64
US$50,521 		6,609 7.64 US$50,521
2024-01-24 2024-01-23 PrS Proposed sale
2.8
Elisabet de los Pinos

Officer; Director

Executive Director
15,853
7.64
US$121,141 		15,853 7.64 US$121,141
2024-01-24 2024-01-23 S Sale
1.9
Feder Julie B

Chief Financial Officer

Officer
6,609 -9.5%
7.64
US$50,521 		6,609 -9.5% 7.64 US$50,521
2024-01-24 2024-01-23 S Sale
2.8
de los Pinos Elisabet

See Remarks

Executive Director
15,853 -8.9%
7.64
US$121,141 		15,853 -8.9% 7.64 US$121,141
2024-01-08 2024-01-08 PrS Proposed sale
CADMUS C RICH & SHANTEL C RICH JT TEN

Officer

Officer
10,000
8.85
US$88,500 		10,000 8.85 US$88,500
2024-01-02 2024-01-02 PrS Proposed sale
CADMUS C RICH & SHANTEL C RICH JT TEN

Officer

Officer
9,748
8.86
US$86,367 		9,748 8.86 US$86,367
2023-12-15 2023-12-15 PrS Proposed sale
CADMUS C RICH &SHANTEL C RICH JT TEN

Officer

Officer
90,039
8.85
US$796,845 		90,039 8.85 US$796,845
2023-11-09 2023-11-09 B Purchase
1.1
Matrix Capital Management Company, LP
Large shareholder
1,560,000 +29.1%
9.00
US$14,040,000 		1,560,000 +29.1% 9.00 US$14,040,000
2023-11-09 2023-11-08 B Purchase
3.8
Johnson David Michael
Non-Executive Director
10,000 +15.4%
7.30
US$73,000 		10,000 +15.4% 7.30 US$73,000
2023-11-09 2023-11-08 B Purchase
3.8
Johnson David Michael
Non-Executive Director
10,000 +15.4%
7.30
US$73,000 		10,000 +15.4% 7.30 US$73,000
2023-11-09 2023-11-08 B Purchase
3.8
Johnson David Michael
Non-Executive Director
9,601 +7.6%
7.30
US$70,087 		9,601 +7.6% 7.30 US$70,087
Explore more

More insider trading research around Aura Biosciences Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America